Cargando…
The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339740/ https://www.ncbi.nlm.nih.gov/pubmed/34422348 http://dx.doi.org/10.21037/jtd-20-3314 |
_version_ | 1783733653648441344 |
---|---|
author | Heo, Jung Won Lee, Hwa Young Han, Solji Kang, Hye Seon Kwon, Soon Seog Lee, Sook Young |
author_facet | Heo, Jung Won Lee, Hwa Young Han, Solji Kang, Hye Seon Kwon, Soon Seog Lee, Sook Young |
author_sort | Heo, Jung Won |
collection | PubMed |
description | BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had serum lipid profiles including apolipoprotein levels from March 1, 2019 to December 31, 2019. We classified the asthma patients into two groups according to the diagnosis method: (I) patients who were diagnosed based on clinical symptoms/signs and PFT results and (II) patients diagnosed with clinical symptoms/signs. Clinical characteristics including age, underlying diseases, smoking status, allergy test results and treatment agents were compared between the two groups. The associations between blood cholesterol levels including apolipoprotein and pulmonary functions were analyzed. Moreover, patients were divided into two groups according to the median value of apolipoprotein B (Apo B), and lung function test results were compared between the patients who had high and low Apo B levels. RESULTS: Among the 167 patients, 93 (55.7%) were PFT-proven asthma patients. In PFT-proven asthma patients, the levels of total cholesterol (TC) (r =0.37, P=0.03), low-density lipoprotein (LDL) (r =0.46, P=0.01) and Apo B (r =0.38, P=0.02) showed a significant correlation with FeNO, which had no statistical significance in physician-diagnosed asthma group. In multivariate regression analysis, log (FeNO) showed a significant correlation with Apo B (P<0.01) after adjustment for presence of PFT-proven asthma (P=0.01) and current smoking (P=0.01). Patients with high Apo B levels had a lower post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio (69.8 vs. 74.9, P=0.02) and lower post-BD FEV1 (%) (77.5 vs. 85.0, P=0.04) compared with those showing low Apo B levels. CONCLUSIONS: The levels of Apo B and FeNO had positive correlations and high Apo B levels were associated with severe airflow obstruction and low FEV1 (%). Apo B could reflect the uncontrolled status of bronchial asthma and poor lung function. |
format | Online Article Text |
id | pubmed-8339740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-83397402021-08-20 The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients Heo, Jung Won Lee, Hwa Young Han, Solji Kang, Hye Seon Kwon, Soon Seog Lee, Sook Young J Thorac Dis Original Article BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had serum lipid profiles including apolipoprotein levels from March 1, 2019 to December 31, 2019. We classified the asthma patients into two groups according to the diagnosis method: (I) patients who were diagnosed based on clinical symptoms/signs and PFT results and (II) patients diagnosed with clinical symptoms/signs. Clinical characteristics including age, underlying diseases, smoking status, allergy test results and treatment agents were compared between the two groups. The associations between blood cholesterol levels including apolipoprotein and pulmonary functions were analyzed. Moreover, patients were divided into two groups according to the median value of apolipoprotein B (Apo B), and lung function test results were compared between the patients who had high and low Apo B levels. RESULTS: Among the 167 patients, 93 (55.7%) were PFT-proven asthma patients. In PFT-proven asthma patients, the levels of total cholesterol (TC) (r =0.37, P=0.03), low-density lipoprotein (LDL) (r =0.46, P=0.01) and Apo B (r =0.38, P=0.02) showed a significant correlation with FeNO, which had no statistical significance in physician-diagnosed asthma group. In multivariate regression analysis, log (FeNO) showed a significant correlation with Apo B (P<0.01) after adjustment for presence of PFT-proven asthma (P=0.01) and current smoking (P=0.01). Patients with high Apo B levels had a lower post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio (69.8 vs. 74.9, P=0.02) and lower post-BD FEV1 (%) (77.5 vs. 85.0, P=0.04) compared with those showing low Apo B levels. CONCLUSIONS: The levels of Apo B and FeNO had positive correlations and high Apo B levels were associated with severe airflow obstruction and low FEV1 (%). Apo B could reflect the uncontrolled status of bronchial asthma and poor lung function. AME Publishing Company 2021-07 /pmc/articles/PMC8339740/ /pubmed/34422348 http://dx.doi.org/10.21037/jtd-20-3314 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Heo, Jung Won Lee, Hwa Young Han, Solji Kang, Hye Seon Kwon, Soon Seog Lee, Sook Young The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title | The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title_full | The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title_fullStr | The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title_full_unstemmed | The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title_short | The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients |
title_sort | association between serum apolipoprotein b and fractional exhaled nitric oxide in bronchial asthma patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339740/ https://www.ncbi.nlm.nih.gov/pubmed/34422348 http://dx.doi.org/10.21037/jtd-20-3314 |
work_keys_str_mv | AT heojungwon theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT leehwayoung theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT hansolji theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT kanghyeseon theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT kwonsoonseog theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT leesookyoung theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT heojungwon associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT leehwayoung associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT hansolji associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT kanghyeseon associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT kwonsoonseog associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients AT leesookyoung associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients |